Literature DB >> 35092472

Astragaloside IV suppresses migration and invasion of TGF-β1-induced human hepatoma HuH-7 cells by regulating Nrf2/HO-1 and TGF-β1/Smad3 pathways.

Lili Li1, Qin Wang1, Yinghao He1, Liangjie Sun1, Yan Yang2, Xiaonan Pang2,3.   

Abstract

Astragaloside IV (AS-IV), one of the major compounds extract from Astragalus membranaceus, has shown attractive anti-cancer effects in certain malignancies. Oxidative stress (OS) is considered as a crucial factor in promoting the progression of hepatocellular carcinoma (HCC). In response to OS, nuclear factor erythroid 2-related factor 2 (Nrf2) upregulates and induces heme oxygenase 1 (HO-1) to combat oxidative damages. The phosphorylation of the COOH-terminal of Smad3 (pSmad3C) activates p21 to resist HCC progression, while the phosphorylation of the linker region of Smad3 (pSmad3L) up-regulates c-Myc transcription to exert promoting effect towards HCC. This study aimed to explore whether AS-IV suppresses migration and invasion of human hepatoma HuH-7 cells by regulating Nrf2/HO-1 and TGF-β1/Smad3 pathways. HuH-7 cells were induced with TGF-β1 (9 or 40 pM) to establish HCC model in vitro and pretreated with AS-IV at different concentration (5, 10, and 20 μM) for 24 h. Cell proliferation, migration, invasion, and intracellular reactive oxygen species (ROS) of HuH-7 cells were measured. The expression of Nrf2, pSmad3C, Nrf2/pNrf2, HO-1, pSmad3C/3L, c-Myc, and p21 were detected. Exposure of HuH-7 cells to TGF-β1 enhanced the cell proliferation, migration, invasion, and ROS production. Pretreatment with AS-IV (5, 10, and 20 μM) significantly reduced the cell proliferation, migration, invasion, and ROS production in HuH-7 cells. Furthermore, AS-IV increased the expressions of Nrf2/pNrf2, HO-1, pSmad3C, and p21, meanwhile reduced the expressions of pSmad3L and c-Myc. In conclusion, our study suggested that AS-IV inhibit HuH-7 cells migration and invasion, which related to activate Nrf2/HO-1 pathway, up-regulation pSmad3C/p21 pathway, and down-regulation pSmad3L/c-Myc pathway. The present research supports the notion that AS-IV may be a latent agent for the treatment of HCC.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Astragaloside IV; Hepatic carcinoma; HuH-7; Nrf2/HO-1; pSmad3C/p21; pSmad3L/c-Myc

Mesh:

Substances:

Year:  2022        PMID: 35092472     DOI: 10.1007/s00210-021-02199-8

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  3 in total

1.   CUL4B, NEDD4, and UGT1As involve in the TGF-β signalling in hepatocellular carcinoma.

Authors:  Zhaowei Qu; Di Li; Haitao Xu; Rujia Zhang; Bing Li; Chengming Sun; Wei Dong; Yubao Zhang
Journal:  Ann Hepatol       Date:  2016 Jul-Aug       Impact factor: 2.400

2.  Astragaloside IV ameliorates high glucose-induced HK-2 cell apoptosis and oxidative stress by regulating the Nrf2/ARE signaling pathway.

Authors:  Jing Wang; Hong-Min Guo
Journal:  Exp Ther Med       Date:  2019-04-17       Impact factor: 2.447

Review 3.  Oxidative Stress and Liver Cancer: Etiology and Therapeutic Targets.

Authors:  Zhanpeng Wang; Zhuonan Li; Yanshuo Ye; Lijuan Xie; Wei Li
Journal:  Oxid Med Cell Longev       Date:  2016-11-10       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.